Using backward stepwise logistic regression selection, a lung cancer risk prediction model incorporating liver function biomarkers was developed. Enter the calculator interface, inputing personal data of the predictors, the individualized lung cancer risk probabilities can be quickly calculated.
The full model generated a C-index of 0.813 (95%CI, 0.805 to 0.820). Significance was observed when excluding these biomarkers (C-index = 0.802, 95%CI, 0.794 to 0.810, P < 0.001). Similarly, we found significant improvement of both category NRI (0.040, 95% CI, 0.034 to 0.077, P < 0.001) and continuous NRI (0.030, 95% CI, 0.017 to 0.047, P < 0.001). Hosmer-lemeshow test showed the predicted and observed lung cancer risk probabilities agreed well, suggesting that the full model was well calibrated (P value = 0.1631).
This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.
With an Evidencio Community account you can:
A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.
{{ (typeof row === 'object') ? row.label : row }} |
{{ column }} | |
---|---|
{{ row.label }} | {{ value }} |
{{ error }}
Please enter a password
A password has to be at least 8 characters.
A password cannot be longer then 64 characters.
Choose a password with at least one capital letter.
Choose a password with at least one special character (@$!%*#?&)
Please agree to the Terms & Conditions and the Disclaimer
Please provide your e-mail address and we'll send you a link to reset your password.
Email Address
Please enter a valid email
If an account was registered with this email address you will receive a recovery link in your mail.
Please use the reset password link in it to set your new password.
Didn't receive the email yet? Please check your spam folder, or resend the email.